This is the book your physician likely told you to read and follow. Click here for the paperback book on Amazon.com $12.30 Click here for the eBook $9 and instant download from Amazon.
Viibryd withdrawal – How to taper Viibryd is fully described in How to Taper Psychoactive Medication. The full step by step process in detail. Free assistance is also available if needed.
Viibryd Withdrawal Symptoms – What are the symptoms of Viibryd withdrawal described as well as how to eliminate Viibryd withdrawal symptoms.
Viibryd withdrawal – What is the Viibryd withdrawal timeline? You will find that in How to Taper Psychoactive Medication. There is a timeline you should follow for a successful Viibryd withdrawal.
Viibryd withdrawal – Headache is all too common during Viibryd withdrawal. Want the solution? It is found in How to Taper Psychoactive Medication.
Viibryd withdrawal – Some have anxiety during Viibryd withdrawal, and some have fatigue during Viibryd withdrawal. How to Taper Psychoactive Medication gives the solutions.
Viibryd withdrawal – Nausea during Viibryd withdrawal is all too common. It does not need to happen. Read How to Taper Psychoactive Medication for the solution.
Viibryd withdrawal – Do you want a list of virtually all Viibryd withdrawal side effects? Not only does How to Taper Psychoactive Medication give the Viibryd withdrawal side effects but offers solutions.
Viibryd withdrawal – Brain zaps caused by Viibryd withdrawal can be eliminated quickly. Yes, the solution is in How to Taper Psychotropic Medication.
You may have experienced extreme trauma the last time you tried to get off the Viibryd Vilazodone and the apprehension you may feel now is normal, not a mental disorder. This is your time; do not let yourself get rushed by your physician or by the information in this book. The drug manufacturer, the F.D.A., and even the American Medical Association state a gradual reduction of the Viibryd Vilazodone is required. We cannot stress enough, take your time. This is when the tortoise beats the hare to the finish line.
Reducing Viibryd Vilazodone
Viibryd Vilazodone standard withdrawal protocol shows the following:
“Adverse reactions may occur upon discontinuation of VIIBRYD. A gradual reduction in dosage rather than abrupt cessation is recommended whenever possible. VIIBRYD should be down tapered from the 40 mg once daily dose to 20 mg once daily for 4 days, followed by 10 mg once daily for 3 days. Patients taking VIIBRYD 20 mg once daily should be tapered to 10 mg once daily for 7 days.”
The Road Back recommends this protocol for a safe and effective Viibryd Vilazodone withdrawal process.
- Take the Viibryd Vilazodone each day at the same time as you have been. Do not change the time of day you take the Viibryd Vilazodone.
- Take Viibryd Vilazodone with food, just as you should have been before starting the taper. Taking Viibryd Vilazodone without food will alter the absorption rate of the Viibryd Vilazodone and this will likely cause you to have a negative reaction that has nothing to do with tapering the Viibryd Vilazodone.
- If you are taking 40mg of Viibryd Vilazodone daily, for your first reduction take, (1) 20mg tablet and (1) 10mg tablet. This will give you 30mg of Viibryd Vilazodone daily. Dropping down to 20mg daily from 40mg is too extreme of a reduction. Remember, a gradual reduction is advised.
- Remain at 30mg daily for 14 days. Do not cut this short no matter how well you are feeling. And remain at 30mg daily until you feel very stable at that dosage.
- Your next reduction is to take (1) 20mg tablet of Viibryd Vilazodone daily, with food.
- The next lower dosage available of Viibryd Vilazodone is 10mg. This is a large reduction and should not be attempted until you have taken the 20mg dosage for 14 days but most importantly, you feel very stable at the 20mg dosage.
- From the 10mg daily you drop to zero Viibryd Vilazodone daily. This is another large reduction and should only be done after you felt stable at the 10mg dosage for at least 14 days.
If you are taking 20mg of Viibryd Vilazodone when you begin this process
- Take the Viibryd Vilazodone each day at the same time as you have been. Do not change the time of day you take the Viibryd Vilazodone.
- Take Viibryd Vilazodone with food, just as you should have been before starting the taper. Taking Viibryd Vilazodone without food will alter the absorption rate of the Viibryd Vilazodone and this will likely cause you to have a negative reaction that has nothing to do with tapering the Viibryd Vilazodone.
- After at least 14 days on the pre-taper, taking all the supplements used, if you are feeling good, it is time to reduce the Viibryd Vilazodone. Start taking (1) 10mg dosage of the Viibryd Vilazodone daily. Take at the same time each day, as you have been and take with food.
- After 14 days of taking the 10mg Viibryd Vilazodone daily, as long as you feel very stable, no new withdrawal side effects from reducing the Viibryd Vilazodone, you are ready to discontinue the Viibryd Vilazodone.
This is where taking good notes during the pre-taper and taper may become very useful. Look back at your notes and see which supplement helped with which withdrawal side effect.
Generally, it will be the brain zaps and using the Omega 3 Supreme to get rid of them and adjusting how much and when you take the Omega 3 Supreme. If you need assistance send an email to [email protected]
References
1. Stuivenga M, Giltay EJ, Cools O, Roosens L, Neels H, Sabbe B. Evaluation of vilazodone for the treatment of depressive and anxiety disorders. Expert Opin Pharmacother. 2019 Feb;20(3):251-260. doi: 10.1080/14656566.2018.1549542. Epub 2018 Nov 26. PMID: 30475091. [cited 2022 June 14]
2. Walsh WJ (2012). Nutrient Power. Skyhorse Publishing, New York, NY. Crayton JW, Walsh WJ (2007). J Trace Elements Med Biol.21:17-21.[cited 2022 June 14]
3. Hillhouse TM, Porter JH. A brief history of the development of antidepressant drugs: from monoamines to glutamate. Exp Clin Psychopharmacol. 2015;23(1):1-21. doi:10.1037/a0038550 [cited 2022 June 14]
4. Knapen J, Vancampfort D, Moriën Y, Marchal Y. Exercise therapy improves both mental and physical health in patients with major depression. Disabil Rehabil. 2015;37(16):1490-5. doi: 10.3109/09638288.2014.972579. Epub 2014 Oct 24. PMID: 25342564. [cited 2022 June 14]
5. Cuomo A, Maina G, Bolognesi S, Rosso G, Beccarini Crescenzi B, Zanobini F, Goracci A, Facchi E, Favaretto E, Baldini I, Santucci A, Fagiolini A. Prevalence and Correlates of Vitamin D Deficiency in a Sample of 290 Inpatients With Mental Illness. Front Psychiatry. 2019 Mar 29;10:167. doi: 10.3389/fpsyt.2019.00167. PMID: 31001150; PMCID: PMC6455075. [cited 2022 June 14]
6. Rao TS, Asha MR, Ramesh BN, Rao KS. Understanding nutrition, depression and mental illnesses. Indian J Psychiatry. 2008;50(2):77-82. doi:10.4103/0019-5545.42391 [cited 2022 June 14]
7. Briguglio M, Dell’Osso B, Panzica G, et al. Dietary Neurotransmitters: A Narrative Review on Current Knowledge. Nutrients. 2018;10(5):591. Published 2018 May 10. doi:10.3390/nu10050591 [cited 2022 June 14]
8. Pandya CD, Howell KR, Pillai A. Antioxidants as potential therapeutics for neuropsychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2013;46:214-223. doi:10.1016/j.pnpbp.2012.10.017 [cited 2022 June 14]
9. Osher Y, Belmaker RH. Omega-3 fatty acids in depression: a review of three studies. CNS Neurosci Ther. 2009 Summer;15(2):128-33. doi: 10.1111/j.1755-5949.2008.00061.x. PMID: 19499625; PMCID: PMC6494070. [cited 2022 June 14]
10. Yeung KS, Hernandez M, Mao JJ, Haviland I, Gubili J. Herbal medicine for depression and anxiety: A systematic review with assessment of potential psycho-oncologic relevance. Phytother Res. 2018 May;32(5):865-891. doi: 10.1002/ptr.6033. Epub 2018 Feb 21. PMID: 29464801; PMCID: PMC5938102. [cited 2022 June 14]
11. Firth J, Gangwisch J, Borsini A, Wootten R, Mayar E, Food and Mood – How do Diet and Nutrition Affect Mental Well-being? BMJ 2020;369:m2382 [cited 2022 June 14]
12. Substance Abuse and Mental Health Services Administration. DSM-5 Changes: Implications for Child Serious Emotional Disturbance [Internet]. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2016 Jun. Table 9, DSM-IV to DSM-5 Major Depressive Episode/Disorder Comparison. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519712/table/ch3.t5/ [cited 2022 June 14]
13. World Health Organization fact sheet, Depression [published online 13 Sept 2021] [cited 2022 June 14]
14. Treatment-resistant depression: no panacea, many uncertainties. Adverse effects are a major factor in treatment choice. Prescrire Int. 2011 May;20(116):128-33. PMID: 21648180. [cited 2022 June 14]
15. Nanthakumaran S, Sridharan S, Somagutta MR, Arnold AA, May V, Pagad S, Malik BH. The Gut-Brain Axis and Its Role in Depression. Cureus. 2020 Sep 6;12(9):e10280. doi: 10.7759/cureus.10280. PMID: 33042715; PMCID: PMC7538207. [cited 2022 June 14]
16. Prasko J. Bright light therapy. Neuro Endocrinol Lett. 2008 Nov;29 Suppl 1:33-64. PMID: 19029878. [cited 2022 June 14]
17. Ljungberg, Tina et al. “Evidence of the Importance of Dietary Habits Regarding Depressive Symptoms and Depression.” International journal of environmental research and public health vol. 17,5 1616. 2 Mar. 2020, doi:10.3390/ijerph17051616[cited 2022 June 14]
18. David D, Cristea I, Hofmann SG. Why Cognitive Behavioral Therapy Is the Current Gold Standard of Psychotherapy. Front Psychiatry. 2018;9:4. Published 2018 Jan 29. doi:10.3389/fpsyt.2018.00004 [cited 2022 June 14]
19. Zell M, Grundmann O. An orthomolecular approach to the prevention and treatment of psychiatric disorders. Adv Mind Body Med. 2012 Fall;26(2):14-28. PMID: 23341413. [cited 2022 June 14]
20. Mason LH, Harp JP, Han DY. Pb neurotoxicity: neuropsychological effects of lead toxicity. Biomed Res Int. 2014;2014:840547. doi: 10.1155/2014/840547. Epub 2014 Jan 2. PMID: 24516855; PMCID: PMC3909981. [cited 2022 June 14]
21. Gore AC, Chappell VA, Fenton SE, Flaws JA, Nadal A, Prins GS, Toppari J, Zoeller RT. EDC-2: The Endocrine Society’s Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocr Rev. 2015 Dec;36(6):E1-E150. doi: 10.1210/er.2015-1010. Epub 2015 Nov 6. PMID: 26544531; PMCID: PMC4702494. [cited 2022 June 14]
22. Sharma A, Madaan V, Petty FD. Exercise for mental health. Prim Care Companion J Clin Psychiatry. 2006;8(2):106. doi:10.4088/pcc.v08n0208a [cited 2022 June 14]